Submissions from 2023
Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease., Jill R Krissberg, Michelle M O'Shaughnessy, Abigail R Smith, Margaret E Helmuth, Salem Almaani, Diego H Aviles, Kaye E Brathwaite, Yi Cai, Daniel Cattran, Rasheed Gbadegesin, Dorey A Glenn, Larry A Greenbaum, Sandra Iragorri, Koyal Jain, Myda Khalid, Jason Kidd, Jeffrey Kopp, Richard Lafayette, Jerome C Lane, Francesca Lugani, Jordan G Nestor, Rulan S Parekh, Kimberly Reidy, David T Selewski, Christine B Sethna, C John Sperati, Katherine Tuttle, Katherine Twombley, Tetyana L Vasylyeva, Donald J Weaver, Scott E Wenderfer, Keisha Gibson, and CureGN Consortium
Assessment of medication adherence among adults with glomerular disease, JR Krissberg, Katherine Tuttle, and See all authors in comments
The Effect of Preoperative Carbohydrate Intake on Length of Stay and Postoperative Recovery Following Laparoscopic Living Donor Nephrectomy., Morgan Kuiper, Melanie Gillingham, Julie Martin, Daniella Gardner, and Sandra Van Calcar
“Research Coordinator Mentoring Program – Participant Presentations”, Kelli Kuykendall
Comparison of clinical diabetes outcomes of patients managed via telemedicine pharmacists during the COVID pandemic relative to continued management by primary care clinics, Trevor Laursen and Stephanie Chan
Equity and Quality of Global CKD Care - what are we waiting for?, Valerie A Luyckx, Ayah Elmaghrabi, Manisha Sahay, Nicole Scholes-Robertson, Laura Sola, Tobias Speare, Elliot K Tannor, Katherine Tuttle, and Ikechi G Okpechi
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis., Laura H Mariani, Sean Eddy, Fadhl M AlAkwaa, Phillip J McCown, Jennifer L Harder, Viji Nair, Felix Eichinger, Sebastian Martini, Adebowale D Ademola, Vincent Boima, Heather N Reich, Jamal El Saghir, Bradley Godfrey, Wenjun Ju, Emily C Tanner, Virginia Vega-Warner, Noel L Wys, Sharon G Adler, Gerald B Appel, Ambarish Athavale, Meredith A Atkinson, Serena M Bagnasco, Laura Barisoni, Elizabeth Brown, Daniel C Cattran, Gaia M Coppock, Katherine M Dell, Vimal K Derebail, Fernando C Fervenza, Alessia Fornoni, Crystal A Gadegbeku, Keisha L Gibson, Laurence A Greenbaum, Sangeeta R Hingorani, Michelle A Hladunewich, Jeffrey B Hodgin, Marie C Hogan, Lawrence B Holzman, J Ashley Jefferson, Frederick J Kaskel, Jeffrey B Kopp, Richard A Lafayette, Kevin V Lemley, John C Lieske, Jen-Jar Lin, Rajarasee Menon, Kevin E Meyers, Patrick H Nachman, Cynthia C Nast, Michelle M O'Shaughnessy, Edgar A Otto, Kimberly J Reidy, Kamalanathan K Sambandam, John R Sedor, Christine B Sethna, Pamela Singer, Tarak Srivastava, Cheryl L Tran, Katherine Tuttle, Suzanne M Vento, Chia-Shi Wang, Akinlolu O Ojo, Dwomoa Adu, Debbie S Gipson, Howard Trachtman, and Matthias Kretzler
Prediction of kidney failure using multiple data domains in glomerulonephropathy: A CureGN study, LH Mariani, Katherine Tuttle, and See all authors in comments
Comparison of in-clinic only to in-clinic plus virtual mental health screens of adults with cystic fibrosis during SARS-CoV-2 pandemic, KG Mertz, M Ingoldby, T Vance, and AA Lambert
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection., Erin D Michos, George L Bakris, Helena W Rodbard, and Katherine Tuttle
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection., Erin D Michos, George L Bakris, Helena W Rodbard, and Katherine R Tuttle
Improvement: Increasing staff and patient awareness of and knowledge of genetic therapy research, JE Milton, A Chavez, K Kuykendall, and AA Lambert
Quality Improvement: Increasing staff and patient awareness of and knowledge of genetic therapy research, Joan Milton
“Cardiac Amyloid Pearls & Pitfalls”, Deirdre Mooney
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update., Sankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, Juliana C N Chan, Hiddo J L Heerspink, Clint Hurst, Adrian Liew, Erin D Michos, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Jonathan C Craig, David J Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Peter Rossing, Ian H de Boer, and Kamlesh Khunti
A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A Scientific Statement from the American Heart Association., C Ndumele, Katherine Tuttle, and See all authors in comments
First-line therapy in T2D: Has Metformin been “dethroned, Joshua J Neumiller and Radica Alicic
Incorporating Evidence and Guidelines for Personalized Care of Diabetes and Chronic Kidney Disease., Joshua J Neumiller, Radica Alicic, and Katherine Tuttle
Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States., Susanne B Nicholas, Radica Alicic, and Jenny Shen
Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States., Susanne B Nicholas, Radica Z Alicic, and Jenny Shen
Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020., Susanne B Nicholas, Kenn Daratha, Radica Alicic, Cami R Jones, Lindsey M Kornowske, Joshua J Neumiller, Samuel T Fatoba, Sheldon X Kong, Rakesh Singh, Keith C Norris, and Katherine Tuttle
Operative and oncological outcomes of salvage robotic radical and partial nephrectomy: a multicenter experience., Kennedy E Okhawere, Ralph Grauer, Laura Zuluaga, Kirolos N Meilika, Burak Ucpinar, Alp Tuna Beksac, Shirin Razdan, Indu Saini, Chiya Abramowitz, Ronney Abaza, Daniel D Eun, Akshay Bhandari, Ashok K Hemal, James Porter, Michael D Stifelman, Mani Menon, and Ketan K Badani
Transperitoneal Versus Retroperitoneal Robotic-Assisted Partial Nephrectomy in Patients with Obesity., Kennedy E Okhawere, Jordan Miller Rich, Alp Tuna Beksac, Laura Zuluaga, Indu Saini, Burak Ucpinar, Joshua Levieddin, Iretiayo T Joel, Anthony Deluxe, Michael D Stifelman, Simone Crivellaro, Ronney Abaza, Daniel D Eun, Akshay Bhandari, Ashok K Hemal, James Porter, Ahmed Mansour, Phillip M Pierorazio, Osama Zaytoun, and Ketan K Badani
Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial., Erika A Petersen, Thomas G Stauss, James A Scowcroft, Michael J Jaasma, Elizabeth S Brooks, Deborah R Edgar, Judith L White, Shawn M Sills, Kasra Amirdelfan, Maged N Guirguis, Jijun Xu, Cong Yu, Ali Nairizi, Denis G Patterson, Kostandinos C Tsoulfas, Michael J Creamer, Vincent Galan, Richard H Bundschu, Neel D Mehta, Dawood Sayed, Shivanand P Lad, David J DiBenedetto, Khalid A Sethi, Johnathan H Goree, Matthew T Bennett, Nathan J Harrison, Atef F Israel, Paul Chang, Paul W Wu, Charles E Argoff, Christian E Nasr, Rod S Taylor, David L Caraway, and Nagy A Mekhail
Noninvasive testing for advanced fibrosis in patients with diabetes with fatty liver disease needs further evaluation of cutoff values., Pankaj Rajvanshi and Srikrishna Gurumurthy
(543) Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol, Adriana Rauseo, Tatyana Der, Radica Alicic, Bindu Balani, Caryn Morse, Pearl Zakroysky, Linda Shaw, Jane Atkinson, and William G. Powderly
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis., Michelle N Rheault, Charles E Alpers, Jonathan Barratt, Stewart Bieler, Pietro Canetta, Dong-Wan Chae, Gaia Coppock, Ulysses Diva, Loreto Gesualdo, Hiddo J L Heerspink, Jula K Inrig, Gianna M Kirsztajn, Donald Kohan, Radko Komers, Laura A Kooienga, Kenneth Lieberman, Alex Mercer, Irene L Noronha, Vlado Perkovic, Jai Radhakrishnan, William Rote, Brad Rovin, Vladimir Tesar, Hernán Trimarchi, James Tumlin, Muh Geot Wong, Howard Trachtman, DUPRO Steering Committee and DUPLEX Investigators, and Katherine Tuttle
Spontaneous Rupture of a Previously Asymptomatic Giant Angiomyolipoma, Reed Ritterbusch
Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes, Patricia Rodriguez, Samuel Gratzl, Ryan Lee, Sarah Gilson, Peter Smits, Nicholas L Stucky, and Tyler J Gluckman
Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease., Kyle M Rose, Katie S Murray, Craig Labbate, Solomon Woldu, Jennifer Linehan, Joseph Jacob, Hristos Kaimakliotis, Rian Dickstein, Adam Feldman, Surena F Matin, Yair Lotan, Mitchell R Humphreys, and Wade J Sexton
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease., Peter Rossing, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, and Richard Pratley
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease., Peter Rossing, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, and Richard Pratley
1460-P: Prevalence of Chronic Kidney Disease Associated with Type 1 Diabetes in the U.S., Peter Rossing, Per-Henrik Groop, Rakesh Singh, Robert Lawatscheck, and Katherine Tuttle
Phase II doseselection, randomized double-blind trial of the ASI, BI 690517, alone and in combination with EMPA in people with CKD, P Rossing, Katherine Tuttle, and Full List of Authors in Comments
Prevalence of chronic kidney disease associated with type 1 diabetes in the US, P Rossing, Katherine Tuttle, and See full list of authors in comments
Evaluation of an Integrated Intervention to Address Clinical Care and Social Needs Among Patients with Type 2 Diabetes., Sarah E Roth, Benjamin Gronowski, Kyle Jones, Rachel A Smith, Sonya Kauffman Smith, Keri B Vartanian, and Bill J. Wright
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial., William E Russell, Brian N Bundy, Mark S Anderson, Laura A Cooney, Stephen E Gitelman, Robin S Goland, Peter A Gottlieb, Carla J Greenbaum, Michael J Haller, Jeffrey P Krischer, Ingrid M Libman, Peter S Linsley, S Alice Long, Sandra M Lord, Daniel J Moore, Wayne V Moore, Antoinette M Moran, Andrew B Muir, Philip Raskin, Jay S Skyler, John M Wentworth, Diane K Wherrett, Darrell M Wilson, Anette-Gabriele Ziegler, and Kevan C Herold
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis., Pantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, Christoph Wanner, Gerasimos Filippatos, John Boletis, Katherine R Tuttle, Luis M Ruilope, Peter Rossing, Robert Toto, Stefan D Anker, Zhi-Hong Liu, Amer Joseph, Christiane Ahlers, Meike Brinker, Robert Lawatscheck, George Bakris, and FIDELIO-DKD and FIGARO-DKD Investigators
Comprehensive Understanding of Hispanic Caregivers: Focus on Innovative Methods and Validations., Ujala Sehar, Priyanka Rawat, Moumita Choudhury, Annette Boles, John Culberson, Hafiz Khan, Keya Malhotra, Tanisha Basu, and P Hemachandra Reddy
Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Propensity-matched Analysis., Gopal Sharma, Milap Shah, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J Challacombe, Mahendra Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M Buffi, Ananthakrishanan Sivaraman, James R Porter, Craig Rogers, Alexandre Mottrie, Ronney Abaza, Khoon Ho Rha, Daniel Moon, Thyavihally B Yuvaraja, Dipen J Parekh, Umberto Capitanio, Kris K Maes, Francesco Porpiglia, Levent Turkeri, and Gagan Gautam
Robot-assisted partial nephrectomy in morbidly obese patients: a VCQI database study., Gopal Sharma, Gurpremjit Singh, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J Challacombe, Mahendra Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M Buffi, Sivaraman Ananth, James R Porter, Craig Rogers, Alexandre Mottrie, Ronney Abaza, Khoon Ho Rha, Daniel Moon, Thyavihally B Yuvaraja, Dipen J Parekh, Umberto Capitanio, Kris K Maes, Francesco Porpiglia, Levent Turkeri, and Gagan Gautam
Response to COVID-19: The Outpatient Dialysis Setting., Jeffrey Silberzweig, Sylvia Wu, Matthew Sinclair, Thomas Watson, Nancy Welder, Danilo Concepcion, Jerry Yee, Felicia Speed, Daniel Cukor, Brigitte Schiller, and Daniel Weiner
Clinical Practice Panel: Diabetes Mellitus Management in a Medical-Surgical Unit, Jane Tajonera
Hospital-Based, Community Teaching Kitchen Integrates Diabetes Education, Culinary Medicine, and Food Assistance: Case Study During the COVID-19 Pandemic., Jacob P Tanumihardjo, Heidi Davis, Jill Christensen, Rachel A Smith, Sonya Kauffman Smith, and Kathryn E Gunter
Enhancing Chronic-Disease Education through Integrated Medical and Social Care: Exploring the Beneficial Role of a Community Teaching Kitchen in Oregon., Jacob P Tanumihardjo, Heidi Davis, Mengqi Zhu, Helen On, Kayla K Guillory, and Jill Christensen
Analysis of eGFR vs CrCl to monitor for renal dose adjustments within Central Refill, Briana Thompson and Angela Koerner
Targeting of insulin receptor endocytosis as a treatment to insulin resistance., Bryce Tim, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
2023 Cardiometabolic Health Congress (CMHC) Women’s Health and Wellness Masterclass, Katherine Tuttle
“90% of people with chronic kidney disease don’t know they have it. Do you know the risk factors?”, Katherine Tuttle
“Cardiorenal Disease: Can reducing the risks improve outcomes?”, Katherine Tuttle
Chair – Targeting Muscle, Kidney & Liver, Katherine Tuttle
CKD in Diabetes and the Journey to Kidney Health, Katherine Tuttle
Clinicopathologic Conference “ Nephrotic Syndrome”, Katherine Tuttle
“Comparative effectiveness of GLP-1 receptor agonists vs DPP-4 inhibitors in patients type 2 diabetes, Katherine Tuttle
“Comparative effectiveness of GLP-1 receptor agonists vs. SGLT2 inhibitors”, Katherine Tuttle
Destination Kidney Health for Diabetes and CKD, Katherine Tuttle
Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors., Katherine Tuttle
Effects of Long COVID, Katherine Tuttle
“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”, Katherine Tuttle
“FDA approves new indication for Jardiance”, Katherine Tuttle
“GLP1 RAs and Kidney Outcomes in Diabetes”, Katherine Tuttle
Harvard Medical School – Diabetes Comorbidities and Complications, Katherine Tuttle
“Implementation of a New Era of Goal-Directed Medical Therapy for Patients with Cardiorenal Disease”, Katherine Tuttle
“Incretin Trials: Trying new directions”, Katherine Tuttle
“Jardiance approved for adults with Chronic Kidney Disease”, Katherine Tuttle
KDIGO Conference on CKD, Rome Italy, Katherine Tuttle
Kidney Health in View for Diabetes and CKD, Katherine Tuttle
Late breaking clinical trials: “Asi in CKD”, Katherine Tuttle
Most Powerful Tools Ever to Slow the Progression of Diabetic Kidney Disease: How and When to Use them Optimally”, Katherine Tuttle
Multidisciplinary Strategies for Implementation, Katherine Tuttle
National Academies of Sciences, Engineering, and Medicine, Preparing the Future Workforce in Drug Research and Development Workshop – Speaker, Katherine Tuttle
“ Non-insulin therapies for people living with T2D”, Katherine Tuttle
“On par with the biggest breakthroughs in medicine”, Katherine Tuttle
“Outsize benefit seen in trial of drug for kidney disease”, Katherine Tuttle
“Prediction of kidney failure using multiple data domains in glomerulonephropathy: A CureGN study”, Katherine Tuttle
“Preserving Kidney Health in Diabetes”, Katherine Tuttle
Protective effects of GLP-1 Receptor Agonists, Katherine Tuttle
Providence IM/FM Resident’s Lecture “CKD in Diabetes and Beyond. Entering A New Era of Kidney Health” Spokane, WA, Katherine Tuttle
“Racial and Ethnic Disparities in Acute Care Utilization Among Patients with Glomerular Disease”, Katherine Tuttle
"Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes", Katherine Tuttle
Research presented at the American Society of Nephrology meeting, Katherine Tuttle
“Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease”, Katherine Tuttle
“Scientists find promising new drug for chronic kidney disease”, Katherine Tuttle
“SGLT2 inhibitors and GLP-1 receptor agonist: mechanisms of beneficial action beyond, Katherine Tuttle
“Spokane doctor’s breakthrough kidney disease treatment shows promising results”, Katherine Tuttle
“The Journey to Kidney Health is the Reward for People with Diabetes and CKD”, Katherine Tuttle
“The Kidney | SGLT2 Inhibitors and GLP-1”, Katherine Tuttle
“Therapeutic Transformation of Kidney Care by Groundbreaking Clinical Trials”, Katherine Tuttle
“There is no excuse for the number of people we have on dialysis”, Katherine Tuttle
“Tirzepaztide reduces albuminuria in patients with type 2 diabetes”, Katherine Tuttle
“Unmet need: The epidemiology of CKD & type 1 diabetes”, Katherine Tuttle
USPSTF Kidney Caucus Meeting - Speaker, Katherine Tuttle
A Quality Improvement Initiative to Bridge Gaps in Treatment and Interprofessional Care of CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Research Diversity (AIM-AHEAD), Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Assessment of Medication Adherence Among Adults with Glomerular Disease, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Design and Baseline Characteristics of the FIND-CKD Trial: Efficacy of Finerernone on Kidney Disease Progression in People with non-diabetic CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Diabetic Kidney Disease Collaborative (DKD-C): Addressing the Urgent and Unmet Needs of People with CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Dynamic Bayesian Networks (DBN) Predicted ≥40% Decline in eGFR over Six Years, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Incidence of Chronic Kidney Disease in Prediabetes, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Interim Results from FINE-REAL: A Prospective Study Providing Insights into the Use of Finerenone in Routine Clinical Settings, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
